JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.
Eickhardt-Dalbøge CS, Nielsen HV, Fuursted K, Stensvold CR, Andersen LOB, Lilje B, Larsen MK, Kjær L, Christensen SF, Knudsen TA, Skov V, Sørensen AL, Ellervik C, Olsen LR, Christensen JJE, Nielsen XC, Hasselbalch HC, Ingham AC.
Eickhardt-Dalbøge CS, et al. Among authors: christensen sf.
Eur J Haematol. 2024 May;112(5):776-787. doi: 10.1111/ejh.14169. Epub 2024 Jan 16.
Eur J Haematol. 2024.
PMID: 38226781